IMPLICATIONS OF LIPID AND CARBOHYDRATE METABOLISM IN PERIODONTAL DISEASE ASSOCIATED WITH DIABETES, CARDIOVASCULAR AND NONALCOHOLIC FATTY LIVER DISEASE

  • Dora Maria POPESCU University of Medicine and Pharmacy of Craiova, Romania
  • Allma Roxana PITRU University of Medicine and Pharmacy of Craiova, Romania
  • Cristina FLORESCU University of Medicine and Pharmacy of Craiova, Romania
  • D.N. GHEORGHE University of Medicine and Pharmacy of Craiova, Romania
  • C.M. IONELE University of Medicine and Pharmacy of Craiova, Romania
  • Ana Maria RICA University of Medicine and Pharmacy of Craiova, Romania
  • Maria BOGDAN University of Medicine and Pharmacy of Craiova, Romania

Abstract

The systemic inflammatory response in periodontal disease is characterized by the presence of inflammatory mediators. The systemic inflammatory response positively influences the risk of developing diabetes and its complications, atherosclerotic diseases and other chronic conditions. Metabolic syndrome is a consequence of the modern lifestyle, an accumulation of metabolic abnormalities that increase the cardiovascular risk. Abnormal distribution of adipose tissue with obesity, insulin resistance, and dyslipidemia are some of these abnormalities but also increased blood pressure, atherogenic dyslipidemia, hypertension, and pro-thrombotic and pro-inflammatory status are other conditions. The study’s main objective was to evaluate the hypothesis that inflammatory changes in gingival tissue are correlated to lipid and carbohydrate metabolism abnormalities in patients with diabetes mellitus (DM), cardiovascular disease (CVD), and nonalcoholic fatty liver disease (NAFLD). The medical records of 181 subjects were used in this retrospective study. The results suggested that periodontal disease can influence the systemic level of inflammatory mediators in patients with systemic diseases (DM, CVD, and NAFLD) by mechanisms that rely on oral microbial flora exposure and control. Conclusions: by influencing lipid and carbohydrate metabolism, NAFLD is closely correlated to cardiovascular disease or diabetes, and study into these factors in patients with periodontal disease helps to highlight the association between these diseases.

Author Biographies

Dora Maria POPESCU, University of Medicine and Pharmacy of Craiova, Romania

Department of Periodontology, Research Center of Periodontal-Systemic Interactions

Allma Roxana PITRU, University of Medicine and Pharmacy of Craiova, Romania

Department of Oral Pathology, Research Center of Periodontal-Systemic Interactions

Cristina FLORESCU, University of Medicine and Pharmacy of Craiova, Romania

Department of Internal Medicine

D.N. GHEORGHE, University of Medicine and Pharmacy of Craiova, Romania

Department of Periodontology, Research Center of Periodontal-Systemic Interactions

C.M. IONELE, University of Medicine and Pharmacy of Craiova, Romania

Department of Gastroenterology

Ana Maria RICA, University of Medicine and Pharmacy of Craiova, Romania

Department of Odontology

Maria BOGDAN, University of Medicine and Pharmacy of Craiova, Romania

Department of Pharmacology

References

1. Șurlin P, et al. Optical Coherence Tomography Assessment of Gingival Epithelium Inflammatory Status In Periodontal-Systemic Affected Patients. Annals of Anatomy-Anatomischer Anzeiger 2018; 219: 51- 56.
2. Rosato V, Masarone M, Dallio M, Federico A, Aglitti A, Persico M. NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome. Int J Environ Res Public Health 2019; 16(18): 3415 / doi: 10.3390/ijerph16183415.
3. Lam DW, et al. Metabolic Syndrome. South Dartmouth: MDText.com, Inc., 2019.
4. Heindel JJ, et al. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol 2017; 68: 3-33.
5. Olteanu M, et al. Gingival inflammatory infiltrate analysis in patients with chronic periodontitis and diabetes mellitus. Rom J Morphol Embryol 2011; 52(4): 1311-1317.
6. Lee L, Arrington Sanders R. Metabolic Syndrome. PediatrRev 2012; 33(10): 459-468.
7. Taghizadeh E et al. The atherogenic role of immune cells in familial hypercholesterolemia. IUBMB Life 2020; 72(4): 782-789.
8. Freeman AM, Pennings N. Insulin resistance. Treasure Island, Florida: Stat Pearls Publishing, 2020.
9. Huaizhu Wu, Christie M Ballantyne. Metabolic Inflammation and Insulin Resistance in Obesity. Circ Res 2020; 126(11): 1549-1564.
10. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. TherAdvCardiovasc Dis 2017; 11(8): 215-225.
11. Bogdan M, et al. Effect of 0.2% Chlorhexidine’ s Use For Treatment Of Localized Gingival Lesions In Patients With Type 2 Diabetes, Rev Chim 2016; 67(12): 2651-2653.
12. Adeva-Andany MM, Pérez-Felpete N, Fernández-Fernández C, Donapetry-García C, Pazos-García C. Liver glucose metabolism in humans. Biosci Rep 2016; 36(6): e00416.
13. Hanes PJ, Krishna R. Characteristics of inflammation common to both diabetes and periodontitis: are predictive diagnosis and targeted preventive measures possible? EPMA J. 2010; 1(1): 101-116.
14. Huang R, Yan L, Lei Y. The relationship between high-density lipoprotein cholesterol (HDL-C) and glycosylated hemoglobin in diabetic patients aged 20 or above: a cross-sectional study. BMC Endocr Disord 2021; 21: 198 / doi: 10.1186/s12902-021-00863-x.
15. Macedo Paizan ML, Vilela-Martin JF. Is There an Association between Periodontitis and Hypertension ? CurrCardiol Rev 2014; 10(4): 355-361.
16. Sanz M, et al. Periodontitis and Cardiovascular Diseases. Consensus Report. J Clin Periodontol 2020; 47(3): 268-288.
17. Siloşi I, et al. Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis, Int J Mol Sci 2017; 18(6): 1304 / doi: 10.3390/ ijms18061304.
18. Deprince A, Haas JT, Staels B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. MolMetab 2020; 42: 101092 / doi: 10.1016/j.molmet.2020.101092.
19. Ajmera V, et al. Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease. Hepatology 2017; 65(1): 65-77.
20. Cardoso EM, Reis C, Manzanares-Céspedes MC. Chronic periodontitis, inflammatory cytokines, and interrelationship with other chronic diseases. Postgrad Med 2018; 130(1): 98-104.
21. Tandon N, Ali MK, Narayan KMV. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes. Am J Cardiovasc Drugs 2012; 12: 7-22.
22. Fentoğlu O, Oz G, Taşdelen P, Uskun E, Aykaç Y, Bozkurt FY. Periodontal status in subjects with hyperlipidemia. J Periodontol 2009; 80(2): 267-273.
23. Kumar P, Mastan K, Chowdhary R, Shanmugam K. Oral manifestations in hypertensive patients: A clinical study. J Oral MaxillofacPathol 2012; 16(2): 215-221.
24. Pham TAV, Tran TTP. The interaction among obesity, Type 2 diabetes mellitus, and periodontitis in Vietnamese patients. ClinExp Dent Res 2018; 4(3): 63-71.
25. Dhir S, Wangnoo S, Kumar V. Impact of Glycemic Levels in Type 2 Diabetes on Periodontitis. Indian J EndocrinolMetab 2018; 22(5): 672-677.
26. Rajhans NS, Kohad RM, Chaudhari VG, Mhaske NH. A clinical study of the relationship between diabetes mellitus and periodontal disease. J Indian SocPeriodontol 2011; 15(4): 388-392.
27. Posch Machado AC, de Souza Quirino MR, Costa Nascimento LF. Relation between chronic periodontal disease and plasmatic levels of triglycerides, total cholesterol and fractions. Braz Oral Res 2005; 19(4): 284-249.
28. Totan A, Greabu M, Totan C, Spinu T. Salivary aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase: possible markers in periodontal diseases? Clin Chem Lab Med 2006; 44(5): 612-615.
29. Bogdan M, et al. Salivary and serum biomarkers for the study of side effects of aripiprazole co prescribed with mirtazapine in rats, Int J Clin Exp Med 2015; 5(8):8051-8059
30. Kei Takamisawa, et al. Association between serum IgG antibody titers against Porphyromonas gingivalis and liver enzyme levels: A cross-sectional study in Sado Island. Heliyon 2020; 6(11): e05531.
31. Yoneda M, et al. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol 2012; 12: 16 / doi: 10.1186/1471-230X-12-16.
Published
2021-12-30
Section
INTERNAL MEDICINE - PEDIATRICS